CureGenix Corporation
- Headquarters
- Guangzhou
- Business Model
- B2B
- Last Round
- Series AOct 2016
- Rounds
- 2
Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.
About
CureGenix Corporation is a Guangzhou, China-based biopharmaceutical company developing vaccine and immuno-oncology candidates, including proprietary nanoparticle adjuvant technology and PD-1/PD-L1 antibody compositions licensed for combination immunotherapy. The company's research is cited in peer-reviewed vaccine-adjuvant studies and referenced across multiple U.S. patent filings covering programmed death receptor antibody compositions.
Summary
CureGenix Corporation is a Biotech company based in Guangzhou, China. Its most recent funding was a Series A round in Oct 2016. Investors include F-Prime Capital and Eight Roads Ventures.
Funding History
Oct 2016
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/curegenix-corporation"><img src="https://indexed.vc/api/badge/company/curegenix-corporation" alt="CureGenix Corporation on Indexed.vc" width="260" height="76" /></a>